2-Hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: Influence of the alkylation of position 4

We report herein the synthesis of a series of fifteen 2-hydroxyisoquinoline-1,3(2H,4H)-dione derivatives. Alkyl and arylalkyl groups were introduced on position 4 of the basis scaffold. All the compounds presented poor inhibitory properties against HIV-1 reverse transcriptase ribonuclease H (RNase H). Four compounds inhibited HIV-1 integrase at a low micromolar level. A docking study using the later crystallographic data available for PFV integrase allowed us to explain the slightly improved integrase inhibitory activities of 4-pentyl and 4-(3-phenylpropyl)-2-hydroxyisoquinoline-1,3(2H,4H)-diones, when compared to the basis scaffold. Physicochemical studies were consistent with 1:1 and 1:2 (metal/ligand) stoichiometries of the magnesium complexes in solution. Unfortunately all tested compounds exhibited high cellular cytotoxicity in cell culture which limited their applications as antiviral agents. However these identified integrase inhibitors provide a very good basis for the development of new hits.

A series of 2-hydroxyisoquinoline-1,3(2H,4H)-dione derivatives substituted on position 4 by alkyl and arylalkyl groups was synthesized. Their inhibitory properties of HIV-1 integrase and reverse transcriptase RNase H function were evaluated.Figure optionsDownload as PowerPoint slideResearch highlights
► 2-Hydroxyisoquinoline-1,3-diones as HIV-1 integrase inhibitors.
► Influence of an alkyl chain on position 4.
► The work correlates experimental (biological) and theoretical (docking) results.